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Abstract 
In the development of the mammalian intestine, Notch and Wnt/-catenin signals control stem 
cell maintenance and their differentiation into absorptive and secretory cells. Mechanisms that 
regulate differentiation of progenitors into the three secretory lineages, goblet, paneth or 
enteroendocrine cells, are not fully understood. Using conditional mutagenesis in mice, we 
observed that Shp2-mediated MAPK signaling determines the choice between paneth and goblet 
cell fates and also stem cells, which express the leucine-rich repeat-containing receptor 5 (Lgr5). 
Ablation of the tyrosine phosphatase Shp2 in the intestinal epithelium reduced MAPK signaling 
and led to a reduction of goblet cells while promoting paneth cell development. Conversely, 
conditional mitogen-activatged protein kinase kinase 1 (Mek1) activation rescued the Shp2 
phenotype, promoted goblet cell and inhibited paneth cell generation. The Shp2 mutation also 
expanded Lgr5+ stem cell niches, which could be restricted by activated Mek1 signaling. Changes 
of Lgr5+ stem cell quantities were accompanied by alterations of paneth cells, indicating that 
Shp2/MAPK signaling might affect stem cell niches directly or via paneth cells. Remarkably, 
inhibition of MAPK signaling in intestinal organoids and cultured cells changed the relative 
abundance of Tcf4 isoforms and by this, promoted Wnt/-catenin activity. The data thus show 
that Shp2-mediated MAPK signaling controls the choice between goblet and paneth cell fates by 
regulating Wnt/-catenin activity. 
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Introduction 
The intestinal epithelium of mammals consists of absorptive enterocytes and of three secretory 
cell types, paneth, goblet and enteroendocrine cells, which are continuously replenished from 
stem cells that reside in niches in the lower parts of the crypts (1, 2). The secretory lineages 
differentiate from a common progenitor that emerges to occupy the +5 cell position above the 
stem cell niches (3). Goblet and paneth cells continue to share similar characteristics, while 
enteroendocrine cells develop separately through a divergent mechanism. During differentiation, 
paneth cells move back to the base of the crypts and become interspersed between the stem 
cells, while the other cell types migrate into the villi (1, 2). Paneth cells provide signals for the 
maintenance of stem cells, which are characterized by the expression of the stem cell marker 
Lgr5. Lgr5 is a receptor for R-spondins and participates in canonical Wnt signaling (4). Lgr5+ stem 
cells are reduced but not depleted when paneth cells are lacking (5, 6), which indicates that 
paneth cells are not the sole source of the signals that maintain stem cells. 
Wnt/-catenin signaling, through cooperation of Wnt receptors and Lgr4/5 co-receptors, is 
essential in maintaining the intestinal epithelium, and plays important roles in the generation of 
Lgr5+ stem cells (1). Canonical Wnt signaling also influences secretory cell lineages, since 
overexpression of the Wnt antagonist  dickkopf1 (Dkk1) lead to a loss of all secretory cell types 
(7). However, Wnt/-catenin signaling has different effects on the development of the three 
secretory cell types: paneth cells require Wnt and Lgr4 (8, 9), high Wnt activity interferes with 
goblet cell differentiation (10), while enteroendocrine progenitors are Wnt-independent (11). This 
indicates that additional mechanisms come into play in the differentiation of the secretory 
lineages. One candidate might be MAPK signaling, because conditional expression of oncogenic 
K-ras resulted in intestinal hyperplasia and was accompanied by altered goblet and paneth cell 
numbers (12). 
The non-receptor tyrosine phosphatase Shp2 mediates growth factor and cytokine signals and 
can regulate the activity of the Ras/Mek1/MAPK and other signaling pathways in development 
and disease (13, 14). In mice, a null mutation of Shp2 interfered with the expansion of the 
trophoblast cell lineage and led to implantation deficits (15). Shp2 is also required for the 
development and maintenance of the nervous system, the kidney and other organs (13, 14, 16, 
17); its role in the maintenance of the intestinal epithelium is not fully investigated. Heterozygous 
mutation of Shp2 in an Egfr mutant background resulted in the accumulation of desquamated 
intestinal epithelia (18). Shp2 and the transcription factor Stat3 are activated through the 
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interleukin/gp130 receptor; however, mutation of the Shp2-binding site in gp130 has no major 
effects on intestinal development. Instead, it enlarges the proximal small intestine in aging mice 
and protects intestines from dextran sulphate-induced colitis (19). 
Here we used mouse genetics to demonstrate that Shp2 and Mek1/MAPK signaling control the 
choice between goblet and paneth cell fates. Ablation of Shp2 promotes paneth cell expansion 
while reducing goblet cell formation. Conversely, activation of Mek1/MAPK promotes the 
generation of goblet cells at the expense of paneth cells. We provide evidence that 
Shp2/Mek1/MAPK-mediated regulation of Wnt/-catenin signaling is crucial for the lineage 
decision by which goblet and paneth cells differentiate from a common progenitor cell type.  
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Results 
Shp2 is essential for goblet cell differentiation: 
We aimed to assess the role of Shp2/MAPK signaling in cell fate determination of the intestine. 
By conditional mutagenesis, we generated mutant mice that lacked Shp2 in the intestine using 
villinCre (Shp2lox/lox; villinCre and Shp2lox/+; villinCre, hereafter called Shp2 mutant and control, 
respectively, see Material and Methods (16, 20)). Remarkably, ablation of Shp2 strongly reduced 
goblet cell numbers in the small intestine and the colon, as assessed by alcian blue staining (Fig. 
1 A, B). The intervention was accompanied by a drop in mRNAs of Spdef, Muc2 and Gob5, which 
are typically expressed in goblet cells (21-23), as assessed by qRT-PCR (Fig. 1 C, D). 
Immunohistochemical analysis (IHC) of Spdef and Gob5 proteins confirmed reduced goblet cell 
numbers (Fig. S1 A, B, quantification on the right). The Shp2 mutant phenotype was mildly 
mosaic: goblet cell numbers were reduced in a pronounced manner in large areas that displayed 
high levels of Cre protein and loss of Shp2 expression (Fig. S1 C-E, right panel; residual goblet 
cells only appeared in minor areas with very low or no Cre (C), and with absence of Shp2 
expression (D); yellow arrows point to Shp2-deficient villi and crypts without goblet cells). 
Enteroendocrine cells were not affected by the loss of Shp2, as assessed by IHC for 
ChromagraninA (Fig. S1 F, quantification on the right). The morphology of intestinal villi of Shp2 
mutants was slightly aberrant; some villi appeared to be shortened or thickened (Fig.1 A, upper 
right, Fig. S1 A-D, right). Shp2 mutants also developed diarrhea and anal bleeding, which are 
symptoms of severe colitis, and were growth-retarded (Fig. S1 G). We observed a corresponding 
reduction in mRNA of Aquaporins 7 and 8 in the intestines of Shp2 mutants, as assessed by qRT-
PCR (Fig. S1 H). These genes are known to be downregulated in human and mouse colitis (24). 
The data thus show that the Shp2 mutation in the intestine results in goblet cell deficits and colitis. 
Ablation of Shp2 induces premature differentiation of paneth cells and activates Wnt/-
catenin signaling:  
Differentiated paneth cells that produce lysozyme and matrilysin (MMP7) appear only after birth 
(25) and were thus rare in intestines of control mice at P6 (Fig. 2 A, left). Shp2 mutants, however, 
exhibited a massive increase in paneth cells at this stage (Fig. 2 A, right, quantification in Fig. 2 
B), which indeed appear only in Shp2-deficient crypts (Fig. S2 A, yellow arrow points to Shp2-
deficient crypt with paneth cells, blue arrowhead points to a non-recombined crypt without paneth 
cells). The noted expansion of paneth cells potentially mimics an increase in canonical Wnt 
J. Heuberger et al. 2014 
 
6 
 
signals. Wnt signaling has been implicated in paneth cell differentiation (8), and accordingly, 
administration of Wnt3a increases paneth cell numbers in intestinal organoid cultures (26). 
Increases of paneth cells were also noted after tamoxifen-induced ablation of Shp2 in intestinal 
organoids from villinCreERT2 mice, as assessed by IHC or qRT-PCR for lysozyme (Fig. 2 C, Fig. 
S2 B). This led us to examine whether the effects of the Shp2 mutation and the enhanced paneth 
cell differentiation are mediated by activation of canonical Wnt signaling. We performed genome-
wide expression analyses on mutant and control intestines using Illumina microarrays 
(GSE50785), and then used gene set enrichment analysis to compare these with data previously 
obtained on Wnt/-catenin-dependent genes in the intestine (27, 28). Shp2 mutant intestines 
exhibited a marked upregulation of Nol5a, Myc, and Cd44 and several other Wnt/-catenin-
dependent genes (Fig. 2 D, Fig. S2 C). Increases in the expression of Wnt3, the Wnt target gene 
Cd44, and genes encoding Lgr4 and the closely related Lgr5 were also noted in Shp2 mutant 
intestines, as confirmed by qRT-PCR (Fig. 2 E). Thus, Wnt/-catenin signaling is indeed 
enhanced after Shp2 ablation in the murine small intestine. 
Also upregulated in Shp2 mutants was the gene Lgr5, which is normally uniquely expressed in 
stem cells (1). We used the Lgr5-IRES-GFP-CreERT allele to identify Lgr5+ stem cells by IHC for 
GFP (29) and observed an increase in their numbers in Shp2 mutant mice (Fig. 2 F). This was 
confirmed by in situ hybridization for Olfm4, another marker of Lgr5+ stem cells (Fig. 2 G, cf. (30)). 
Next, we compared genes that are deregulated in Shp2 mutant intestines to those of Lgr5+ stem 
cells (31). Remarkably, many stem cell genes were increased in the small intestine of Shp2 
mutants (Fig. 2 H, Fig. S2 D). Further work using qRT-PCR demonstrated an upregulation of stem 
cell genes, including Ascl2, Adora1, Clca4, Aqp1 and Smoc2 in the mutants (Fig. 2 I, marked in 
bold in Fig. S2 D). Thus, ablation of Shp2 in the intestine leads not only to enhanced paneth cell 
differentiation, but also increases a presumptive Lgr5+/Olfm4+ stem cell population. 
Shp2 controls Erk1/2-MAPK signaling in the intestinal crypts: 
In many cell types, Shp2 activates Mek1, which in turn phosphorylates Erk1/2. Immunohistological 
analysis of control intestines demonstrated high nuclear phospho-Erk1/2 levels in goblet cells as 
well in cells located in the lowest part of the villi and in the upper parts of the crypts; phospho-
Erk1/2 levels were strongly reduced in the Shp2 mutant (Fig. 3 A, Insets), reinforcing the notion 
that Shp2 might control goblet and paneth cell differentiation through the regulation of 
Mek1/MAPK signaling. To pursue this, we took advantage of a transgenic mouse strain that 
expresses a gain-of-function variant of Mek1 (Mek1DD) upon removal of a translation stop 
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cassette through Cre-mediated recombination (Fig. S3 A) (32, 33). Mek1DD expression could be 
activated by villinCre in the Shp2 mutant background. In the intestine of Mek1DD; Shp2 double 
mutants at P6, nuclear p-Erk1/2 levels were strongly elevated (Fig. S3 B, right), but overall 
proliferation was not significantly changed, as assessed by Ki67 staining (Fig. S3 C, D). 
Remarkably, the Shp2-dependent reduction of goblet cells both in the small intestine and the 
colon was rescued in Mek1DD; Shp2 double mutants (Fig. 3 B, right, Fig. S3 E). The numbers of 
rescued goblet cells in the intestine were comparable to goblet cell numbers in control mice (Fig. 
S3 F). Further, paneth cells were strongly reduced in Mek1DD; Shp2 double mutants at P6 and 
P16, as shown by Lysozyme staining (Fig. 3 C, Fig. S3 G). Loss of paneth cells was previously 
observed in mice that express an oncogenic variant of K-Ras, and suggested to be caused by 
increased Hes1 expression (12). However, Hes1 expression was not significantly changed in 
Shp2 single and Mek1DD; Shp2 double mutants (Fig. S3 H). Thus, in Mek1DD; Shp2 double 
mutant mice goblet cells are rescued, and this appears to occur at the expense of paneth cells. 
This is reminiscent of the phenotype observed after overexpression of the Ets transcription factor 
Spdef; Spdef overexpression promoted goblet cell differentiation at the expense of paneth cells 
(22). In control mice, goblet and paneth cells produce the Ets transcription factor Spdef, as 
assessed by IHC (Fig. 3 B, marked by arrows on the left). In Shp2 mutants, Spdef production was 
observed in the few residual goblet cells (Fig. 3 B, located in villi) as well as in paneth cells (located 
in crypts, middle panel). In Mek1DD; Shp2 double mutants, the production of Spdef was limited 
to the rescued goblet cells in the villi (Fig. 3 B, right). Apparently, Mek1 activity in intestinal 
epithelial cells does not change the cell type-specific expression pattern of Spdef. Overall, we 
conclude that Mek1/MAPK signaling regulates the choice between goblet and paneth cell 
differentiation.  
The Shp2 mutation does not only affect goblet and paneth cell fates, but also increases the 
presumptive Lgr5+ stem cells (see above, Fig. 2 F). We therefore analyzed stem cells in Mek1DD; 
Shp2 double mutants, and observed downregulated expression of Lgr5, Olfm4 and Ascl2 by in 
situ hybridization and qRT-PCR (Fig. 3 D, Fig. S3 I). Thus, Shp2/MAPK signaling also controls 
the number of stem cells.  
Shp2/Mek1 signaling regulates the secretory cell fate switch by interfering with -
catenin/Tcf4 signaling: 
The transcription factor Tcf4 activates Wnt/-catenin targets genes and is critical for the 
maintenance and differentiation of intestinal epithelia (34, 35). Since mutation of the Tcf4 gene in 
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the adult small intestine induced a paneth to goblet cell transition (35), we analyzed Tcf4 
production in the small intestine by immunohistochemistry. Nuclear Tcf4 protein was observed 
throughout the entire crypt-villus axis, with the strongest levels in the crypts (Fig. S4 A). Goblet 
cells in controls also showed strong nuclear Tcf4 (Fig. S4, inset a). However, no difference in Tcf4 
production was observed between control and Shp2 mutants (Fig. S4 A). However, Tcf4 splice 
variants with different transcriptional capacities might be differentially produced (36) and regulate 
cell fate decisions in the intestinal crypts. To analyze this, we took advantage of organoid cultures 
of the small intestine, which finally consist mainly of crypt structures. Organoids with ablated Shp2 
or activated Mek1DD confirmed the inverse correlation of paneth cells and pErk activities, as 
assessed by immunofluorescence and Western blotting (Fig. 4 A, B). Two major Tcf4 protein 
isoforms were produced in control organoids but remarkably, Shp2 mutant organoids showed 
reduced amounts of the shorter isoform, which was rescued by the Mek1DD allele (Fig. 4 B, the 
shorter Tcf4 isoform is marked by an arrow). The longer isoform at 70kDa is Tcf4E, which harbors 
a binding site for the transcription factor carboxy-terminal binding protein (CtBP) and an extended 
C-terminal domain including a C-clamp, which is a further DNA binding domain (37). In contrast, 
the shorter Tcf4 band at 50kDa (arrow in Fig.4B) corresponds to the Tcf4M and S isoforms, which 
lack the binding sites for CtBP and carry no or an incomplete C-clamp (37). The Tcf4M and S 
isoforms can therefore bind to Wnt response elements on the DNA but lack the capacity of 
promoter activation, for instance of the Wnt target gene Axin2 (37). The different amounts of the 
Tcf4 isoforms by changed MAPK signaling is regulated on the translational level, since the 
mRNAs for the Tcf4 isoforms were not altered between control and mutant organoids (Fig. S4 B). 
Moreover, in human HT29 colon cancer cells, pharmacological inhibition of MEK1/2 by the small 
molecule U0126 also produced reduced amounts of the shorter TCF4M/S isoforms in 
concentration and time-dependent manners (Fig. 4 C, Fig. S4 C, D). Reduction of the TCF4M/S 
isoforms was rapid, starting already at 3h, and was significantly reduced at 6h of MEK1/2 inhibition 
(Fig. 4 D, S4 E), at time-points when the large TCF4 isoform was not significantly altered. 
Importantly, pharmacological inhibition of MEK1/2 by U0126 also rapidly increased the expression 
of the canonical Wnt target gene AXIN2, already at 3h (Fig. 4 E, left). However, upregulation of 
the paneth cell differentiation marker Lysozyme occurred only after 24h of MEK1/2 inhibition (Fig. 
4 E, right). shRNA-mediated knockdown of SHP2 in HT29 cells did not affect MEK1/2 activity (Fig. 
S4 F), which is in line with the fact that HT29 cells harbor an oncogenic B-RAF mutation (38) that 
activates MAPK signaling downstream of SHP2. Furthermore, shSHP2 interference did not alter 
the expression of the TCF4 isoforms (Fig. S4 F), indicating that the alterations of the TCF4M/S 
isoforms are regulated by MEK1/2 signaling and not via other SHP2-mediated events. Co-
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immunopreciptiation of TCF4 with -catenin from nuclear fractionations showed that the 
interaction of -catenin with TCF4E was persistent upon MEK1/2 inhibition (Fig. S4 G). To pursue 
further the mechanism of the MEK1/2-dependent reduction of TCF4M/S proteins, we inhibited 
proteasome protein degradation with MG132. Remarkably, this inhibition prevented the MEK1/2-
dependent reduction of the shorter TCF4M/S isoforms (Fig. 4 F, quantification in Fig. 4 G), 
indicating that MEK1/2 activity protects the shorter isoforms from proteasomal degradation. In 
conclusion, MEK1/2 inhibition appears to affect canonical Wnt signaling by rapidly changing the 
relative abundance of the TCF4 isoforms, i.e., suppressing the transcriptionally inactive/inhibitory 
isoforms, while leaving the activating form unchanged. These data thus suggest that 
Shp2/Mek1/MAPK signaling regulates the choice between goblet and paneth cell fate by 
regulating Wnt/-catenin signaling through interfering with the protein stability of particular Tcf4 
isoforms.  
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Discussion  
Goblet and paneth cells represent two secretory cell types in the intestinal epithelium. Here we 
show that in mouse intestinal development, the tyrosine phosphatase Shp2 promotes the 
generation of goblet cells at the expense of paneth cells. Conditional Shp2 ablation in the 
intestine, which decreases MAPK signaling, reduces the numbers of goblet cells and increases 
the numbers of paneth cells. In contrast, sustained activation of MAPK signaling by the Mek1DD 
allele has the converse effects. Paneth and goblet cells express overlapping sets of genes (22, 
39), and cells with initially intermediary phenotypes have indeed been described (35, 40). Paneth 
and goblet cells are thus closely related and originate from a common precursor (scheme in Fig. 
S5, left). The third secretory lineage, enteroendocrine cells, is generated independently of Shp2 
and MAPK activity, and is believed to diverge from secretory precursors at an earlier stage of 
development (Fig. S5, left) (41). Overall, our data thus show that the level of Shp2/MAPK signaling 
determines the choice between goblet and paneth cell fates. 
 
We also found that Shp2/MAPK attenuates canonical Wnt signaling, which may mediate the effect 
of Shp2/MAPK on the goblet/paneth cell fate changes: goblet cells differentiate, when MAPK and 
Wnt activity are high and low, respectively, whereas paneth cells differentiate, when MAPK and 
Wnt signals are low and high, respectively (Fig. S5, left). Our analysis of mutant intestinal organoid 
cultures and of HT29 colon cancer cells using pharmacological interference is supporting such a 
model and provides mechanistic insights: MAPK inhibition increases Wntcatenin signaling and 
promotes paneth cell characteristics, whereas high MAPK activity or inhibition of Wnt signaling 
favors goblet cell properties (Fig. S5, right). 
 
The Shp2 mutation also triggers colitis and reduced body weight, which are fully rescued by MAPK 
activation. Shp2/Mek1DD double mutant mice are viable and develop no diarrhea or anal 
bleeding. For function, Shp2 is recruited to several tyrosine kinase receptors and other cell 
surface receptors (13). Compound Egfrwa-2; Shp2+/- mutants exhibited intestinal defects, like 
desquamated epithelia and shortened villi (18), which are also observed in mild form in conditional 
Shp2 mutants. Furthermore, Egfr activity is known to control the maturation of goblet cells (42), 
whereas ErbB2, ErbB3 and ErbB4 receptors promote the recovery from chemically induced colitis 
(43, 44). Thus, Shp2 might act downstream of tyrosine kinase receptors like the Egfr in intestinal 
development and prevention of disease. Moreover, we show that MAPK acts downstream of Shp2 
in intestinal development, since activation of MAPK signaling fully rescued the Shp2 phenotypes, 
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i.e. the deficits in goblet/paneth cell fate determination and the colitis. Loss of paneth cells and an 
increase of goblet cell numbers were also observed in intestines after conditional overexpression 
of oncogenic K-rasG12D (12). In addition, K-rasG12D produced hyperplastic polyps and severely 
distorted crypt architecture, which we do not observe in the Mek1DD mutants. The loss of paneth 
cells was attributed to Ras-mediated expression of the transcription factor Hes1 (12). In contrast, 
we did not observe changes in Hes1 expression in Mek1DD or Shp2 mutants. In Ras mutant 
intestines, no effect on Wnt signaling has been reported (12). In contrast, oncogenic Ras acted 
synergistically with canonical Wnt signaling in APC mutant intestines (45). Apparently, oncogenic 
K-Ras controls larger sets of downstream signaling events than Shp2 and Mek1, which may 
explain the additional phenotypes.  
 
We observed that Shp2/MAPK signaling affected canonical Wnt activity in the intestinal 
epithelium: high Shp2/MAPK activity decreased Wnt/-catenin signals and promoted goblet cell 
differentiation, whereas Shp2 ablation increased Wnt/-catenin activity and promoted paneth cell 
differentiation (Fig. S5, right). Canonical Wnt signals downstream of MAPK thus appear to control 
the choice between goblet and paneth cell differentiation, as is also indicated by genetic analysis 
of Tcf4 (35). A common secretory precursor has recently been located at the +5 position in small 
intestines (3). Cells at the +5 position are believed to receive intermediary levels of Wnt/-catenin, 
and our data show that these cells also display intermediary MAPK activity. In contrast, highest 
canonical Wnt activity is observed at the base of the crypts (46), whereas MAPK signaling (as 
assessed by nuclear pErk1/2 distribution) is high in the upper part of the crypts. We therefore 
suggest that the balance between Wnt/-catenin and Shp2/MAPK activities controls the choice 
between goblet/paneth cell differentiation in these precursors.  
 
To define mechanisms by which Shp2/MAPK exert a negative effect on Wnt/-catenin activity, we 
analyzed intestinal organoids genetically, and colon cancer cells using pharmacological inhibition. 
We observed that Shp2 and MAPK signaling interfere with the production of Tcf4 isoforms. Tcf4 
transcription factors are critical for the differentiation and maintenance of intestinal epithelia (34, 
35). Different variants of Tcf4 proteins exist that are generated from differentially spliced mRNAs, 
and exhibit different transcriptional activation capacities (36, 37). The shorter isoform corresponds 
to Tcf4M/S, which lack the CtBP-binding and transactivation motifs (37). In contrast, the longer 
Tcf4E isoform exhibits the unique capacity of promoter recognition and activation, based on the 
extended C-terminal domain. Tcf4E and Tcf4M/S proteins are produced in intestinal organoids 
and colon cancer cells, and reduction of MAPK markedly decreased the levels of the short 
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Tcf4M/S isoforms, i.e. reduced the production of the Tcf4 isoforms with the lower/inhibitory 
potential of Wnt target gene activation. Inhibition of proteasomes prevented the degradation of 
the TCF4M/S isoform, indicating that active MAPK signaling stabilizes this TCF4 isoform, 
presumably by affecting an E3 ligase that targets TCFM/S for degradation. Thus, MAPK signaling 
can influence Wnt target gene activation by regulating the protein stability of isoforms of TCF4 
transcription factors. It has been shown that changes in the relative abundance of Tcf4 variants 
can indeed fine-tune target gene expression in a cell context-dependent manner (47).  Since the 
Tcf4M/S proteins can bind -catenin, we assume that by reducing these isoforms by MAPK 
inhibition, more -catenin becomes accessible for canonical Wnt target gene activation through 
the large Tcf4E transcription factor. Thus, we provide here evidence for a unique mechanistic link 
between MAPK and canonical Wnt signaling in intestinal secretory progenitors. 
 
Ablation of Shp2 in the intestine triggers both an increase in paneth cells and an increase in the 
number of epithelial stem cells, as assessed by gene enrichment profiling and histological 
analyses. This connection is interesting because the control of the small intestinal stem cell niches 
has generally been assigned to paneth cells, which provide Wnt signals known to be essential for 
the maintenance of stem cells (4). Paneth cells do not seem to be solely responsible for this, 
however: sustained activation of MAPK resulted in the complete loss of paneth cells, decreasing 
but not completely eliminating the presumptive Lgr5+ stem cells. Thus, the absence of paneth 
cells did not completely disrupt the stem cell niches. This confirms recent work that noted a 
decrease but not complete loss of Lgr5+ stem cells after genetic ablation of paneth cells (5, 6). 
By contrast, in organoid cultures the interaction between the two cell types is crucial: Lgr5+ stem 
cells are only able to generate organoids in the presence of paneth cells (4, 26). This difference 
suggests that in vivo, additional cell types such as stromal components might produce factors that 
allow stem cell maintenance in the absence of paneth cells (5, 6). Ablation of Shp2 could increase 
the numbers of Lgr5+ cells indirectly, i.e. by increasing the numbers of paneth cells that in turn 
produce factors that stimulate stem cells. This view is supported by experiments that stimulation 
of Wnt signaling produced supernumerary paneth and Lgr5+ cells (26). Alternatively, increased 
Wnt signaling might allow the maintenance of supernumerary Lgr5+ stem cells or impair their 
differentiation. Further work is required to identify the factors that paneth cells and other cell 
populations provide to stem cells in the small intestine.  
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Methods 
Breeding conditions and genotyping of the mouse strains, Shp2lox, villinCre, villinCreERT2 and 
Lgr5-EGFP-IRES-creERT2, have been described (16, 20, 29). All animal experiments were 
conducted according to regulations established by the Max Delbrück Center together with the 
Landesamt für Gesundheit und Soziales (LAGeSo) and the European Union. Mouse intestines 
were fixed in 4% (wt/vol) formaldehyde and immunohistochemistry, immunofluorescence and in 
situ hybridization were performed on 5-μm paraffin sections. Primary antibodies were anti-
pErk1/2, pStat3 (Cell Signaling), Shp2, Mmp7 (Santa Cruz), Lysozyme (Dako), Gob5, ChroA 
and GFP (Abcam), Ki67 (Neolabs), Cre (Novagen) and SPDEF (kindly provided by JA Whitsett, 
Cincinnati Children's Hospital Medical Center, USA). For immunofluorescence, cyanine-labeled 
secondary antibodies (Jackson Immunoresearch) and for immunohistochemistry, HRP-
conjugated polymer and DAB reagent (DAKO) were used. In situ hybridization was performed 
using digoxygenin-labeled (DIG) RNA probes (Roche, Indianapolis, IN). Western blotting was 
performed as described (16) on organoid and cell culture lysates, and blots were probed with 
anti-Shp2 (Santa Cruz), pErk1/2 (Sigma), Lysozyme (Dako), -catenin (BDbioscience), Erk1/2 
and TCF4 (Cell Signaling) antibodies. 
Nuclei from HT29 cells were enriched as described before (48) followed by brief sonification, and 
co-immunoprecipitions were performed at 4°C with anti--catenin antibody (BDbioscience) and 
Protein-G-sepharose (GEhealthcare). Beads were washed four times with PBS/NP40 (0,1%), and 
immunoprecipitated proteins were analyzed by Western blotting. RNA was isolated from pieces 
of proximal small intestine, which was processed for gene profiling (Illumina) according to the 
manufacturer’s protocol (Illumina total prep, Ambion, Life Technologies). Gene set enrichment 
analysis was performed using GESA software from the Broad Institute (27). 
Cells were cultured in DMEM supplemented with 10% FCS (Gibco) and treated with 10µM U0126 
(Calbiochem) for 3h-24h or as indicated. Proteasomes were inhibited for 6h by 25µM of MG132 
(Sigma) with or without 10µM U0126. Organoid culture (49) was performed with supplement from 
HEK293 cells, which overexpressed recombinant R-spondin1. The R-spondin1 plasmid was a gift 
of Christof Niehrs, Mainz. Tamoxifen-inducible Shp2 mutant organoids were split two days before 
treatment with 400nM 4-hydroxitamoxifen (4-OHT) (Sigma) for two consecutive days and were 
cultured for further 4 days.  
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Figure legends 
Fig. 1: (A, B) Reduction of goblet cells in the small intestine (A) and colon (B) of villinCre-induced 
Shp2 loss-of-function mutant mice at P9, as seen on paraffin sections stained with alcian blue. 
(C, D) Reduction of goblet cell-specific mRNA expression in the small intestine (C) and the colon 
(D) in Shp2 mutant mice at P9, assessed by qRT-PCR (n=5, significance calculated with T-Test; 
*:p<0,05, **:p<0,01). Counterstaining; nuclear fast red. Scale bars, 100µm. 
 
Fig. 2: (A) Increase of paneth cells in Shp2 mutants at P6, in comparison to controls, as seen on 
paraffin sections stained by immunofluorescence for Shp2 and Mmp7. (B) Quantification of 
lysozyme-postive paneth cells from the experiment in (S2 A) (n=4). (C) Increase of paneth cells 
in organoid cultures of tamoxifen-inducible Shp2 mutants and controls, stained for Lysozyme by 
immunofluorescence; counterstain was with DAPI. (D) Gene set enrichment analysis (GSEA): 
plot of enrichment score of control versus Shp2 mutant intestinal tissues at P6 for the Wnt/-
catenin gene signature. (E) qRT-PCR for mRNAs of Wnt signaling components in the small 
intestine of Shp2 mutant and control mice at P6 (n=5). (F) Identification Lgr5+ cells by 
immunohistochemistry for GFP in Shp2 mutants and controls crossed with Lgr5-IRES-GFP-
CreERT. (G) In situ hybridization for Olfm4 in Shp2 mutants and controls; red asterisks mark 
crypts. (H) GSEA: plot of enrichment score of control versus Shp2 mutant intestinal tissues at P6 
for the Lgr5 stem cell signature. (I) Confirmation of stem cell-associated genes by qRT-PCR at 
P6 (n=5). Scale bars, 100µm. Significance calculated with T-Test; *:p<0,05, **:p<0,01, 
***:p<0,001. 
 
Fig. 3: (A) Immunohistochemistry of phospho-Erk1/2 (for activated Mek1/2 signaling) at P6 on 
sections of control and Shp2 mutant small intestines. (Insets) Magnifications. (B and C) Rescue 
of goblet cell and paneth cell switches in Shp2 mutants by the MekDD1 allele, as shown by 
staining for goblet cells with alcian blue and Spdef (B) and for paneth cells with Lysozyme (C). 
Arrows in B point to Spdef-stained nuclei. Spdef signals are in part overlapping with strong alcian 
blue staining in Mek1DD mutants. (D) Rescue of Olfm4 mRNA expression in Shp2 mutants by 
MekDD1, as shown by in situ hybridization. (Scale bars, 100µm.) 
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Fig. 4: (A) Paneth cell switch in organoid cultures of tamoxifen-inducible Shp2 mutants, Mek1DD; 
Shp2 double mutants and controls, stained for Lysozyme; counterstain was with DAPI. (B) MAPK-
dependent regulation of Tcf4M/S (marked by arrow) production in organoid cultures of tamoxifen-
induced Shp2 and Mek1DD mutants, as analyzed by Western blotting for Shp2, Lysozyme, Tcf4, 
and pErk. (C) MEK1/2 inhibition in HT29 cells with U0126 for 3h and 12h particularly decreased 
the shorter TCF4 (TCF4M/S) splice variant (arrow). (D) Quantification of the time-dependent 
decrease of the TCF4M/S isoforms  in U0126 treated (green bars) and control (grey bars) HT29 
cells. (E) Upregulation of the Wnt target gene AXIN2 (left) and of Lysozyme (right) in HT29 cells 
through MEK1/2 inhibition (green bars) in time-dependent manner (n=3). (F) Prevention of 
degradation of the TCF4M/S isoforms in U0126-treated HT29 cells by inhibition of proteasomes 
with MG132 for 6h. (G) Quantification of the alterations in TCF4M/S proteins following MG132 
treatment (n=3).Significance was calculated with T-Test; *:p<0,05, **:p<0,01, ***:p<0,001. 









